Truist raised the firm’s price target on Mercury Systems (MRCY) to $109 from $102 and keeps a Buy rating on the shares. The company beat consensus across the board, with free cash flows coming in materially ahead of the Street, the analyst tells investors in a research note. The management is focused on improving working capital through supply chain, accelerating customer deliveries, and demand planning, Truist added. Published first on TheFly – the ultimate source for real-time, market-moving breaking f ...

ONEOK Inc. (NYSE:OKE) just distributed $1.07 per share to shareholders on February 13, 2026, marking a 3.88% increase from the previous quarter's $1.03 payout. ...

President Donald Trump is weighing whether the United States should adopt an Australian-style retirement system that requires employers to fund their workers’ retirement savings accounts. Trump said his administration is “very seriously” looking at the Australian system, CNN reported. He also called it a “good plan” that has “worked out very well.” Whether it would work out very well in the U.S. is open to debate. Here’s a closer look at whether an Australian-style system would be better or worse than t ...

Gemini Space Station said on Thursday that it planned to cut up to 200 jobs worldwide, or about a quarter of its workforce, as part of a broader cost-reduction plan. ...

Weight-loss drugmakers Eli Lilly and Novo Nordisk fell after telehealth company Hims & Hers announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.Copenhagen-listed shares of Novo dropped 7% on the news, while Eli Lilly stock fell 6.1% shortly after the opening bell.Hims & Hers stock soared 10%.Novo launched the Wegovy pill in the U.S. early January and CEO Mike Doustdar told CNBC on Wednesday that 170,000 people were already ...

Key Takeaways AZN will report Q4 results on Feb. 10, with consensus estimates of $15.71B in sales and $2.18 EPS.Key oncology drugs Calquence, Lynparza, Tagrisso and Imfinzi, plus Farxiga, are expected to lead sales.AZN's rare disease portfolio and alliance revenues are seen supporting growth, even as operating costs rise.AstraZeneca (AZN) is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, before the opening bell. In the last reported quarter, the company delivered an earnings surpr ...

US stocks turned lower on Thursday in a fruitless search for a reprieve from a building tech sell-off as investors awaited Amazon earnings, assessed Alphabet's big AI spending plans, and digested jobs data that signaled fresh weakness in the labor market. The S&P 500 (^GSPC) moved roughly 1.2% lower, while the Nasdaq Composite (^IXIC) shed 1.5%. The Dow Jones Industrial Average (^DJI) lost over 1%, or more than 500 points. The market is in the midst of a trillion-dollar tech wipeout, as investors weigh ...

US stocks turned lower on Thursday in an apparently fruitless search for a reprieve from a building tech sell-off as investors awaited Amazon earnings, assessed Alphabet's big AI spending plans, and digested jobs data that signaled fresh weakness in the labor market. The S&P 500 (^GSPC) moved roughly 0.9% lower, while the Nasdaq Composite (^IXIC) shed 1.3%. The Dow Jones Industrial Average (^DJI), which includes fewer tech names, edged about 0.5% lower. The market is in the midst of a trillion-dollar te ...

"We are at the beginning of an industrial revolution that will transform every industry. We see $3 trillion to $4 trillion in AI infrastructure spend by the end of the decade." This is what Colette Kress, Nvidia's CFO, said on the company's earnings call for the second quarter of the company's fiscal 2026, which ended July 27, 2025. While this is an absolutely mind-boggling number, that prediction might end up proving to be accurate. That's because there is already a massive sum of capital being invested i ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...